Sunday, January 20, 2013

Average Wholesale Price Fraud Lawyer and Pharmacy Whistleblower Reward Lawyer: Drug Companies that Fraudulently Inflate AWP to Increase Market Share Are The Target of Medicaid Reward Lawsuits by Average Wholesale Price Fraud Lawyer and Pharmacy Whistleblower Lawyer Jason S. Coomer

Average Wholesale Price Fraud Lawyer and Pharmacy Whistleblower Lawyer: Drug Companies that Fraudulently Inflate Average Wholesale Price to Medicaid Are The Target of Whistleblower Reward Lawsuits by Average Wholesale Price Fraud Lawyer and Pharmacy Whistleblower Lawyer Jason S. Coomer

The United States Department of Justices and many states are offering large rewards to pharmacies, drug intermediaries, and other pharmaceutical professionals that are the first to expose drug companies that are fraudulently inflating Average Wholesale Price to Medicaid in order to increase market share and profits.  Pharmacy whistle-blowers and other drug company whistle-blowers have already helped the Federal government and several state governments obtain over $30 Billion dollars in recoveries from large drug companies that have violated the law and committed fraud.

For a confidential review of a potential average wholesale price fraud lawsuit or other drug company fraud whistle-blower lawsuit, please feel free to contact to contact Average Wholesale Price Drug Price Fraud Whistle-blower Lawyer Jason Coomer via e-mail message.

Price Fraud Whistle-blower Lawsuits  Information, Drug Company False Drug Pricing Whistleblower Lawsuit Information, Pharmaceutical Executive Whistleblower Lawsuit Information, Medicaid False Drug Price Lawsuit Information, and Medicare False Drug Pricing Lawsuit Information

Drug companies that engage in schemes to report false and inflated prices for pharmaceutical products are committing drug price fraud and can be held liable for these illegal actions.  The difference between the resulting inflated government payments and the actual price paid by healthcare providers for a drug is referred to as the “spread.” The larger the spread on a drug, the larger the profit for the health care provider or pharmacist who is reimbursed by the government.

The drug companies that commit this fraud know that federal healthcare programs rely on the reported prices to set payment rates and that by increasing the spread they entice pharmacies and other drug intermediaries to use their drug, thus increasing market share.  The problem with this scam is that public health programs such as Medicaid and Medicare end up paying substantially inflated prices for drugs. 

 Pharmaceutical Executives and Pharmacies That Are The First To Properly Expose The Drug Pricing Fraud Can Receive Large Financial Recoveries and Avoid Potential Criminal Liability

Pharmaceutical Executives and pharmacies that commit drug pricing fraud, cooperate with drug price fraud, or fail to report fraudulent drug price schemes can be held liable for criminal and civil prosecution.  In fact, the government is cracking done on drug price fraud schemes and is actively encouraging drug price fraud whistle-blowers to step forward to report fraudulent drug pricing schemes that are costing government health care programs like Medicaid, Medicare, Tricare, and the Veteran's Administration millions of dollars.  Pharmaceutical Sales Executives, Pharmacists, Drug Representatives, and other health care professionals that properly blow the whistle on fraudulent drug pricing schemes can receive a significant recovery on money recovered by being the first to file on Drug Price Medicare fraud, Drug Price Medicaid fraud, Drug Price Tricare fraud, and/or Drug Price VA.

Pharmaceutical executives and representatives who are the original source of specialized knowledge of drug pricing fraud can recover large economic rewards for properly reporting fraudulent drug pricing schemes.  A successful false claims act qui tam claim can not only result in a significant recovery for the drug representative whistleblower, pharmaceutical executive whistleblower, or pharmaceutical accounting whistleblower, but can result in uncovering Medicare price fraud, Medicaid price fraud, Tricare price fraud, and/or VA price fraud that could result in millions or billions of dollars being recovered or saved by taxpayers.

There are several keys to a successful Drug Price Fraud False Claims Act Qui Tam Whistleblower Lawsuit including 1) obtaining original and specialized information of the fraud, 2) being the first to file regarding the specific fraud, and 3) protecting the whistleblower for retaliation.  

For more information on this topic, please feel free to go to the following web page: Drug Price Fraud Whistleblower Lawyer and Inflated Average Wholesale Price Lawyer

No comments:

Post a Comment